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Schizophrenia has been conceived as a disorder of brain connec-
tivity but it is unclear how this network phenotype is related to the
underlying genetics. We used morphometric similarity analysis of
magnetic resonance imaging (MRI) data as a marker of inter-areal
cortical connectivity in three prior case-control studies of psychosis:
in total, N=185 cases and N=227 controls. Psychosis was associated
with globally reduced morphometric similarity (MS) in all 3 studies.
There was also a replicable pattern of case-control differences in
regional MS which was significantly reduced in patients in frontal
and temporal cortical areas, but increased in parietal cortex. Using
prior brain-wide gene expression data, we found that the cortical
map of case-control differences in MS was spatially correlated with
cortical expression of a weighted combination of genes enriched
for neurobiologically relevant ontology terms and pathways. In
addition, genes that were normally over-expressed in cortical areas
with reduced MS were significantly up-regulated in three prior post
mortem studies of schizophrenia. We propose that this combined
analysis of neuroimaging and transcriptional data provides new
insight into how previously implicated genes and proteins, as well
as a number of unreported genes in their topological vicinity on
the protein interaction network, may drive structural brain network
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Psychotic disorders have a lifetime prevalence of 1-3% and1 can be extremely debilitating. However, despite signif-2
icant efforts, the brain architectural changes and biological3
mechanisms causing psychotic disorders are not yet well un-4
derstood and there has been correspondingly limited progress5
in the development of new therapeutics.6
Magnetic resonance imaging (MRI) studies of schizophrenia7
have robustly demonstrated local structural differences in mul-8
tiple cortical areas, subcortical nuclei and white matter tracts9
(1). The most parsimonious explanation of this distributed,10
multicentric pattern of structural change is that it reflects11
disruption or dysconnectivity of large-scale brain networks12
comprising anatomically connected brain areas. However, test-13
ing this dysconnectivity hypothesis of psychotic disorder has14
been constrained by the fundamental challenges in measuring15
anatomical connectivity and brain anatomical networks in16
humans. The principal imaging methods available for this 17
purpose are tractographic analysis of diffusion weighted imag- 18
ing (DWI) and structural covariance analysis of conventional 19
MRI. DWI-based tractography generally under-estimates the 20
strength of long distance anatomical connections, for example 21
between bilateral homologous areas of cortex. Structural co- 22
variance analysis is not applicable to single subject analysis 23
and its biological interpretation is controversial (2). 24
We recently proposed a technique known as “morphome- 25
tric similarity mapping” (3), which quantifies the similarity 26
between cortical areas in terms of multiple MRI parameters 27
measured at each area and can be used to construct whole 28
brain anatomical networks for individual subjects. In keeping 29
with histological results indicating that cytoarchitectonically 30
similar areas of cortex are more likely to be anatomically 31
connected (4), morphometric similarity (MS) in the macaque 32
cortex was correlated with tract-tracing measurements of ax- 33
onal connectivity. Compared to both tractographic DWI-based 34
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networks and structural covariance networks, MS networks35
included a greater proportion of connections between human36
cortical areas of the same cytoarchitectonic class. Individual37
differences in regional mean MS, or “hubness” of cortical nodes38
in MS networks, accounted for about 40% of the individual dif-39
ferences in IQ in a sample of 300 healthy young people. These40
results suggest that MS mapping could provide a useful new41
tool to analyse psychologically relevant biological differences42
in brain structure.43
Here we used MS mapping to test the dysconnectivity hy-44
pothesis of psychosis in three independent case-control MRI45
datasets: the Maastricht GROUP study (83 cases, 68 controls)46
and the Dublin study (33 cases and 82 controls), both made47
available as legacy datasets for the PSYSCAN project, and the48
publicly available Cobre dataset (69 cases and 77 controls); see49
Methods. We mapped case-control MS differences at global50
and nodal levels of resolution individually in each dataset to51
assess replicability and we tested for significant differences52
in network organization that were consistent across studies.53
We used partial least squares (PLS) regression to test the54
hypothesis that this MRI network phenotype of psychosis was55
correlated with anatomically patterned gene expression using56
data from the Allen Human Brain Atlas (AHBA). This analyt-57
ical approach to combine imaging and genomic data has been58
methodologically established (5, 6) and applied in the context59
of neuropsychiatric disorders (7, 8). We used it to test the60
pathogenic hypothesis that the genes most strongly associated61
with case-control differences in MS were enriched: (i) for genes62
that have been ontologically linked to relevant neurobiological63
processes; and (ii) for genes that are abnormally expressed in64
post-mortem studies of schizophrenia.65
Results66
Samples. Socio-demographic and clinical data available on the67
sample are in Table S1. There was considerable heterogeneity68
in clinical measures between studies, e.g., the Maastricht pa-69
tients had relatively low mean scores on psychotic symptoms70
scales.71
Case-control differences in global morphometric similarity.72
Globally, MS was reduced in cases compared to controls in73
all 3 datasets (Fig. S2). Regional MS had an approximately74
Normal distribution over all 308 regions (after regressing age,75
sex and age × sex) and in all 3 datasets there was a signif-76
icant case-control difference in this distribution (P < 0.001,77
Kolmogorov-Smirnoff test). Modal values of regional MS were78
more frequent, and extreme values less frequent, in cases com-79
pared to controls (Figs. 1a and S2).80
Case-control differences in regional morphometric similarity.81
The cortical map of regional MS in Fig. 1 c) summarises82
the anatomical distribution of areas of positive and negative83
similarity on average over controls from all 3 datasets. The84
results are similar to those reported in an independent sample85
(3), with high positive MS in frontal and temporal cortical86
areas and high negative MS in occipital, somatosensory and87
motor cortex. This confirms the replicability of this pattern88
of regional MS in healthy individuals and is consistent with89
prior knowledge that primary cortex is more histologically90
differentiated than association cortex.91
We mapped the t-statistics and corresponding Hedge’s g92
effect sizes for the case-control differences in regional MS at93
each cortical area (Fig. 1 d). A positive t-statistic means 94
MS increased in patients whereas a negative t-statistic means 95
MS decreased. We found somewhat similar patterns of case- 96
control difference across all 3 datasets, with increased regional 97
MS in occipital and parietal areas in patients, and decreased 98
regional MS in frontal and temporal cortex. The case-control 99
t-map for the Dublin study was significantly correlated with 100
both the Maastricht and the Cobre t-maps (r = 0.42, P < 101
0.001 and r = 0.47, P < 0.001, respectively), although the 102
Maastricht and Cobre t-maps were not significantly correlated 103
(r = 0.058, P = 0.31), see Fig. S4. However, a large number 104
of patients in the Maastricht dataset had very low symptom 105
scores (below the threshold for “borderline mentally ill” (9)). If 106
those non-psychotic patients were excluded from the analysis, 107
the Maastricht case-control t-map was correlated significantly 108
with the Cobre map (r=0.22, P < 0.001, see section S6.2). 109
Combining the P -values for case-control differences across 110
all 3 datasets, we identified 18 cortical regions where MS was 111
robustly and significantly different between groups (Fig. 1 e). 112
MS decreased in patients in 15 regions located in the superior 113
frontal, caudal middle frontal, pre-central, pars triangularis 114
and superior temporal areas and increased in 3 regions located 115
in superior parietal and post-central areas (Table S2). 116
To contextualise the regional MS case-control differences, 117
we referred them to two prior classifications of cortical areas: 118
the von Economo atlas of cortex classified by cytoarchitectonic 119
criteria (5); and the Yeo atlas of cortex classified according 120
to resting state networks derived from functional MRI (10, 121
11). MS was significantly reduced in von Economo class 2 122
(association cortex) and in the ventral attention, frontoparietal 123
and default mode Yeo networks (all PF DR < 0.05; Tables S12 124
and S13). 125
There was a strong negative correlation between regional 126
MS in the control subjects and the case-control differences in 127
regional MS (both averaged over all 3 datasets; Pperm = 0.002) 128
(Fig. 1 f). Hence areas with highest positive MS in controls 129
tended to show the greatest decrease of MS in patients; and, 130
conversely, areas with highest negative MS in healthy controls 131
had the greatest increase of MS in psychosis. This result 132
is analogous to the observation that highly connected ‘hub’ 133
regions are the most likely to show reduced connectivity in 134
disease in fMRI and DTI brain networks (12). 135
We tested for correlations between mean MS and a range 136
of clinical measures, including symptom scores, anti-psychotic 137
medication use and cannabis use, see section S6.3. The only sig- 138
nificant associations after FDR correction were with cannabis 139
use, which was positively correlated with mean global MS in 140
the Maastricht study (PF DR = 5×10−4), as well as with mean 141
MS averaged across the 15 regions with significantly decreased 142
MS in Fig. 1e (PF DR=0.0017). 143
Gene expression related to morphometric similarity. We used 144
PLS regression to identify patterns of gene expression that 145
were correlated with the anatomical distribution of case-control 146
MS differences. The first PLS component explained 13% of the 147
variance in the case-control MS differences, combining data 148
from all 3 studies, significantly more than expected by chance 149
(permutation test, P < 0.001). PLS1 gene expression weights 150
were positively correlated with case-control MS differences in 151
the Dublin study (r = 0.49, P < 0.001) and the Cobre study 152
(r = 0.37, P < 0.001) (Fig. 2a); but not in the Maastricht 153
study (r = 0.006, P = 0.94). These positive correlations mean 154
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Fig. 1. Case-control differences in regional MS. a) Distributions of regional MS strength, i.e. the average similarity of each region to all other regions, for cases and controls
from all datasets. b) Distributions of MS strength for a region with significantly reduced MS in cases, namely left hemisphere caudal middle frontal part 1. c) Regional MS
averaged over controls from all 3 datasets. d) t-statistics and Hedge’s g effect sizes for the case-control differences in regional MS in each dataset. e) t-statistics for regional
case-control differences averaged across datasets in all regions and in the 18 cortical areas where the difference was statistically significant across datasets (FDR = 0.05). f)
Scatterplot of mean control regional MS (x-axis) versus case-control t-statistic (y-axis). Control MS (from panel c) is strongly negatively correlated with case-control MS
differences (from panel d) (Pearson’s r=-0.76, P < 0.001). Most cortical regions have positive MS in controls which decreases in patients (47% of regions) or negative MS in
controls which increases in patients (36% of regions). Statistically significant regions are circled in red/blue according to whether their mean t-statistic increases/decreases in
patients.


























































Fig. 2. Gene expression profiles re-
lated to case-control differences in mor-
phometric similarity a) Scatterplot of re-
gional PLS1 scores (weighted sum of
20,647 gene expression scores) versus
case-control differences in regional MS
(Cobre dataset). b) Cortical map of re-
gional PLS1 scores. c) Cortical map of
mean case-control MS differences, aver-
aged across all datasets. Here we in-
clude intra-hemispheric left hemisphere
edges only (see Methods). d) Genes
that are strongly positively weighted on
PLS1 (e.g., LYSMD4) correlate positively
with case-control differences in regional
MS (r = 0.44, P < 0.001); whereas
genes that are strongly negatively weighted
on PLS1 (e.g., C1orf95) correlate nega-
tively with case-control differences in MS
(r = −0.37, P < 0.001).





Fig. 3. Enrichment analysis of
genes transcriptionally related
to morphometric similarity a)
protein-protein interaction (PPI) net-
work for PLS- genes (Z < −3),
highlighted with some of the sig-
nificantly GO enriched biological
processes: “nervous system de-
velopment” in red and “adenylate
cyclase-modulating G-protein cou-
pled receptor signaling pathway”
in blue. The most interconnected
set of proteins were coded by sev-
eral genes previously implicated in
schizophrenia, highlighted in part
b). See the text and section S8.8
for details.
that genes positively weighted on PLS1 are over-expressed155
in regions where MS was increased in patients, whilst nega-156
tively weighted genes are over-expressed in regions where MS157
was decreased in patients (Fig. 2d). Hence genes which are158
positively (or negatively) weighted on PLS1 were related to159
increased (or decreased) MS in cases compared to controls.160
Enrichment analysis of genes transcriptionally related to mor-161
phometric similarity. We found 1110 genes with normalised162
PLS1 weights Z < −3, which we denote the PLS- gene set,163
and 1979 genes with Z > 3, which we denote the PLS+ gene164
set. We first consider PLS- genes (the equivalent results for165
PLS+ genes are also given below).166
We mapped the network of known interactions between pro-167
teins coded by the PLS- gene set (13) (Fig. 3). The resulting168
protein-protein interaction (PPI) network had 341 connected169
proteins and 1022 edges, significantly more than the 802 edges170
expected by chance (permutation test, P < 1−13). We also171
tested the PLS- gene set for significant GO enrichment of172
biological processes and enrichment of KEGG pathways. En-173
riched biological processes included “nervous system develop-174
ment”, “synaptic signaling” and “adenylate cyclase-modulating175
G-protein coupled receptor signaling pathway” (see Dataset176
S1). There were two significantly enriched KEGG pathways:177
“neuroactive ligand-receptor interaction” and “retrograde en-178
docannabinoid signaling” (Fig. S13). The proteins coded by179
genes enriched for “adenylate cyclase-modulating G-protein180
coupled receptor signaling pathway” and the two KEGG path-181
ways formed the most strongly inter-connected cluster of nodes182
in the PPI network, see Fig. 3, compatible with them sharing183
a specialised functional role for GPCR signaling.184
Genes recently reported as over-expressed in post mortem185
brain tissue from patients with schizophrenia (14) were highly186
enriched among genes that were negatively weighted on PLS1187
(permutation test, P < 0.001, after FDR correction). The188
relationship between the sign of PLS1 weights of gene expres-189
sion related to the MRI case-control phenotype and the sign190
of case-control differences in the histological measures of brain191
gene expression was highly non-random (Wilcoxon rank sum192
test, P< 10−26).193
In other words, genes that were up-regulated in post mortem194
brain tissue from patients with schizophrenia are normally over-195
expressed in association cortical areas that have reduced MS in196
psychosis. This association between gene expression in regions 197
with reduced MS and genes up-regulated in schizophrenia was 198
replicated by analysis of two alternative datasets provided by 199
the PsychENCODE consortium (15) and by (16), see section 200
S8.5. We also observed enrichment by genes up-regulated in 201
other psychiatric disorders, e.g., autistic spectrum disorders, 202
which is compatible with the substantial overlap between 203
genes which are up (or down) regulated in common between 204
schizophrenia and other neurodevelopmental disorders (15). 205
The PLS+ genes coded proteins that formed a PPI network 206
with significantly more edges than expected by chance (P< 207
10−6), which was enriched for the biological process “nucleic 208
acid metabolic process” but no KEGG pathways, see Fig. S14. 209
Genes which are down-regulated post mortem in schizophrenia 210
(14) were highly enriched among genes that were positively 211
weighted on PLS1 (permutation test, P < 0.001 after FDR 212
correction). This result was reproduced with genes reported 213
as down-regulated in schizophrenia by (16), although not by 214
the PsychENCODE consortium (15), see section S8.5. 215
There was no significant enrichment of PLS- or PLS+ genes 216
for common sequence variants associated with schizophrenia, 217
derived from a recent genome-wide association study (GWAS) 218
of PGC and CLOZUK samples (17) (P > 0.05). 219
Discussion. 220
Morphometric similarity network phenotypes. Morphometric simi- 221
larity mapping disclosed a robust and replicable cortical pat- 222
tern of differences in psychosis patients. MS was significantly 223
reduced in frontal and temporal cortical areas, and significantly 224
increased in parietal cortical areas. This pattern was consis- 225
tent across 3 independent datasets, with different samples, 226
locations, scanners and scanning parameters. 227
What does this novel MRI phenotype of psychosis represent? 228
Morphometric similarity quantifies the correspondence or kin- 229
ship of two cortical areas in terms of multiple macro-structural 230
features, e.g., cortical thickness, and micro-structural features, 231
e.g., fractional anisotropy (FA), that are measurable by MRI. 232
We assume that high MS between a pair of cortical regions in- 233
dicates that there is a high degree of correspondence between 234
them in terms of cytoarchitectonic and myeloarchitectonic 235
features that we cannot directly observe, given the limited 236
spatial resolution and cellular specificity of MRI. Prior work 237
also showed that morphometrically similar cortical regions are 238




more likely to be axonally connected to each other, i.e., MS is239
a proxy marker for anatomical connectivity (3). We therefore240
interpret the reduced MS we observe in frontal and temporal241
brain regions in psychosis as indicating that there is reduced242
architectonic similarity, or greater architectonic differentiation,243
between these areas and the rest of the cortex, which is proba-244
bly indicative of reduced anatomical connectivity to and from245
the less similar, more differentiated cortical areas.246
There is a well-evidenced and articulated prior theory of247
schizophrenia as a dysconnectivity syndrome, specifically func-248
tional dysconnectivity of frontal and temporal cortical areas249
has been recognised as a marker of brain network disorganiza-250
tion in schizophrenia (18). Our results of reduced MS in frontal251
and temporal cortex - implying increased architectonic differ-252
entiation and decreased axonal connectivity - are descriptively253
consistent with this theory. Our complementary finding of ab-254
normally increased MS in parietal cortex - implying increased255
architectonic similarity and axonal connectivity - is plausible256
but not so clearly precedented, given the relatively limited257
prior data on the parietal cortex in studies of schizophrenia258
as a dysconnectivity syndrome (19, 20).259
Encouragingly, this novel MRI network marker of psychosis260
was highly reliable across three independent and method-261
ologically various case-control studies. This implies that the262
measurement is robust enough to be plausible as a candi-263
date imaging biomarker of cortical network organization in264
large-scale, multi-centre studies of psychosis.265
Transcriptional profiling of MS network phenotypes. In an effort to266
connect these novel MRI phenotypes to the emerging genetics267
and functional genomics of schizophrenia, we first used partial268
least squares to identify the weighted combination of genes269
in the whole genome that has a cortical expression map most270
similar to the cortical map of case-control MS differences.271
Then we tested the mechanistic hypothesis that the genes272
with greatest (positive or negative) weight on PLS1 were273
enriched for genes previously implicated in the pathogenesis274
of schizophrenia.275
We found that the genes that are normally over-expressed276
in frontal and temporal areas of reduced MS in psychosis,277
were significantly enriched for genes that are up-regulated in278
post mortem brain tissue from patients with schizophrenia279
(14). Conversely, the genes that are normally over-expressed280
in parietal and other areas of increased MS in psychosis were281
significantly enriched for genes that are down-regulated in post-282
mortem data (14). This tight coupling between MRI-derived283
transcriptional weights and gene transcription measured his-284
tologically was highly significant and replicated across three285
prior post-mortem datasets.286
Further investigation showed that the proteins coded by287
the PLS- genes formed a dense, topologically clustered inter-288
action network that was significantly enriched for a number of289
relevant GO biological processes and KEGG pathways. The290
cluster of interactive proteins related to GPCR signaling in-291
cluded multiple proteins coded by genes previously linked to292
anti-psychotic mechanisms of action, including DRD4 (21),293
HTR1 (22), NTSR1 (23) and ADRA2C (24); reported in294
transcriptional studies of post-mortem brain tissue, e.g., PT-295
GER3, S1PR1, ITPR2 and EDNRB (14, 25); or associated296
with risk SNPs for schizophrenia, e.g. DRD5, OPRM1 and297
CNR1 (26–28). The remarkable density of therapeutically rel-298
evant genes in the GPCR-related cluster suggests that other,299
topologically neighboring genes may deserve further attention 300
as novel targets for anti-psychotic interventions. 301
Risk genes identified by the largest extant GWAS studies of 302
schizophrenia were not significantly enriched among PLS- or 303
PLS+ genes. Nevertheless, the involvement of PLS- genes fur- 304
ther down the causal pathway is still mechanistically revealing 305
and potentially useful. 306
Methodological considerations. Some limitations of this study 307
should be highlighted. The whole brain data on “normal” brain 308
tissue expression of the genome were measured post mortem in 309
6 adult brains (mean age = 43 years) and not in age-matched 310
subjects or patients with schizophrenia (such data are not 311
currently available to our knowledge). Also, the transcriptional 312
experiments we use to label genes as up- or down-regulated 313
in schizophrenia were performed in regions of the parietal or 314
prefrontal cortex (14), whereas the neuroimaging results are for 315
the whole brain. We have used MRI data from 3 independent 316
studies to measure MS networks but the studies used different 317
scanning protocols, leading to estimation of morphometric 318
similarity between regions on the basis of 7 MRI parameters 319
that were measurable in all studies. Future work could usefully 320
explore the opportunity to further improve sensitivity and 321
reliability of the MS network biomarker of schizophrenia by 322
optimising and standardising the MRI procedures to measure 323
the most informative set of morphometric features. Finally, 324
the datasets have varied, limited clinical information available, 325
making it difficult to assess the clinical significance of the MS 326
phenotype. 327
Materials and Methods 328
329
Samples. We used MRI data from 3 prior case-control studies: the 330
Maastricht GROUP study (29) from the Netherlands; the Dublin 331
dataset which was acquired and scanned at the Trinity College Insti- 332
tute of Neuroscience as part of a Science Foundation Ireland-funded 333
neuroimaging genetics study (“A structural and functional MRI 334
investigation of genetics, cognition and emotion in schizophrenia”); 335
and the publicly available Cobre dataset (30). The Maastricht 336
and Dublin datasets were PSYSCAN legacy datasets. All patients 337
satisfied DSM-IV diagnostic criteria for schizophrenia or other non- 338
affective psychotic disorders. MRI data were quality controlled for 339
motion artifacts (section S1). The Euler number, which quantifies 340
image quality (31), was not significantly different between groups 341
in any of the studies but it was different between studies, indicating 342
that the studies were ranked Dublin > Cobre > Maastricht in terms 343
of image quality (Table S1). 344
Morphometric similarity mapping. The T1-weighted MRI data 345
(MPRAGE sequence) and the diffusion-weighted imaging (DWI) 346
data from all participants were pre-processed using a previously 347
defined computational pipeline (5). Briefly, we used the recon-all 348
(32) and trac-all (33) commands from FreeSurfer (version 6.0). Fol- 349
lowing (3), the surfaces were then parcellated using an atlas with 350
308 cortical regions, derived from the Desikan-Killiany atlas (5, 34). 351
For each region, we estimated 7 parameters from the MRI and DWI 352
data: grey matter volume, surface area, cortical thickness, Gaussian 353
curvature, mean curvature, fractional anisotropy (FA) and mean 354
diffusivity (MD). Each parameter was normalised for sample mean 355
and standard deviation before estimation of Pearson’s correlation 356
for each pair of Z-scored morphometric feature vectors, which were 357
compiled to form a 308× 308 morphometric similarity matrixMi 358
for each participant, i = 1, . . . N (3). 359
Case-control analysis of MS networks. The global mean MS for each 360
participant is the average ofMi. The regional mean MSi,j , for the 361
ith participant at each region, j = 1, . . . , 308, is the average of the 362




jth row (or column) ofMi. For global and regional MS statistics363
alike, we fit linear models to estimate case-control difference, with364
age, sex, and age×sex as covariates. Our main results also replicated365
in subsets of the data balanced for age and sex, see section S5.6.366
P-values for case-control differences in regional MS were combined367
across all 3 studies, using Fisher’s method. The resulting P-value368
for each region which was thresholded for significance using the false369
discovery rate, F DR < 0.05, to control type 1 error over multiple370
(308) tests.371
Transcriptomic analysis. We used the AHBA transcriptomic dataset,372
with gene expression measurements in 6 post-mortem adult brains373
(35) (http://human.brain-map.org), aged 24-57. Each tissue sample374
was assigned to an anatomical structure using the AHBA MRI375
data for each donor (36). Samples were pooled between bilaterally376
homologous cortical areas. Regional expression levels for each gene377
were compiled to form a 308× 20, 647 regional transcription matrix378
(36). Since the AHBA only includes data for the right hemisphere379
for two subjects, in our analyses relating gene expression to MRI380
data we only consider intra-hemispheric left hemisphere edges (37).381
We used PLS to relate the regional MS case-control differences382
(t-statistics from the 152 cortical regions in the left hemisphere, cal-383
culated from intra-left hemispheric edges only) to the post mortem384
gene expression measurements for all 20, 647 genes. PLS uses the385
gene expression measurements (the predictor variables) to predict386
the intra left hemisphere regional MS patient/control t-statistics387
from all 3 datasets (the response variables). The first PLS com-388
ponent (PLS1) is the linear combination of the weighted gene389
expression scores that has a cortical expression map that is most390
strongly correlated with the map of case-control MS differences.391
The statistical significance of the variance explained by PLS1 was392
tested by permuting the response variables 1,000 times. The error in393
estimating each gene’s PLS1 weight was assessed by bootstrapping394
(resampling with replacement of the 308 cortical regions), and the395
ratio of the weight of each gene to its bootstrap standard error was396
used to calculate the Z-scores and hence rank the genes according397
to their contribution to PLS1 (5).398
We constructed PPI networks from the genes with PLS1 weights399
Z > 3 and Z < −3 (all PF DR < 0.05) using STRING version 10.5400
(13). Our key results were robust to changing these thresholds to401
Z > 4 and Z < −4 (all PF DR < 0.01), see section S8.3. We used402
DAVID (38, 39) to calculate enrichments of KEGG pathways and403
GO enrichments of biological processes for genes with Z > 3 or404
Z < −3, using a background gene list of 15,745 brain-expressed405
genes, again see section S8.3 (37).406
We used a resampling procedure to test for enrichment of PLS-407
derived gene sets by genes previously associated with schizophrenia408
by transcriptional data (14). The median rank of each risk gene set409
in the PLS gene list was compared to the median rank of 10,000410
randomly selected brain-expressed gene sets (3).411
Data and code availability. All code and processed data used for the412
analyses will be made available on GitHub on publication.413
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